Clinical Trials

NCT06861465 | COMPLETED | NA
18 participants

eMPower Mechanisms

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-11
Start Date:
2025-02-21
Completion:
2025-07-16
Conditions
  • Primary Biliary Cholangitis (PBC)
Interventions
  • BEHAVIORAL
No Results Yet
NCT06794073 | RECRUITING | NA
17 participants

Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-11
Start Date:
2026-01-31
Completion:
2026-08-31
Conditions
  • Carcinoma, Hepatocellular
  • Neoplasms, Glandular and Epithelial
  • Adenocarcinoma
  • Digestive System Neoplasms
  • Liver Neoplasms
Interventions
  • DEVICE
No Results Yet
NCT06793215 | RECRUITING | PHASE3
600 participants

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-11
Start Date:
2025-10-24
Completion:
2028-11-30
Conditions
  • Non-Small Cell Lung Cancer
  • KRAS G12C Lung Cancer
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page